Dyskinesias

15 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Dyskinesias
Treatment and conditionWhere it standsTrials
AB-1001 Gene Therapy for huntington diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Active, self-directed electrical stimulation of the median nerve for ticsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
adaptive deep brain stimulation + conventional deep brain stimulation for dyskinesiasTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
apomorphine infusion for dyskinesiasTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Baclofen for psychomotor agitationPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
CUE1 non-invasive device for dystoniaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
High doses of Thiamine y Biotin for huntington diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
intra-striatal rAAV5-miHTT for huntington diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)2
Lifus for dystoniaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Lithium sulphate prolonged-release 660 mg for tremorTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Moderate doses of Thiamine y Biotin for huntington diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + SRP-1005 for huntington diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tominersen for choreaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Tominersen for huntington diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)4
Votoplam (blinded) for huntington diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1